OXURION SUCCESSFULLY RAISES EUR >10 MILLION FROM LEADING US AND EUROPEAN HEALTHCARE INVESTORS IN A PRIVATE EQUITY PLACEMENT

To read the full press release, please see: Latest news | Oxurion — Advancing Science. Enhancing Vision

Attachment

  • Project Owl (EN)- Limited version PIPE PR
Thrombogenics Nv (LSE:0G99)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more Thrombogenics Nv Charts.
Thrombogenics Nv (LSE:0G99)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more Thrombogenics Nv Charts.